$2.33
-0.11-4.53%
Last update: Oct 27, 10:45 AM
Nautilus Biotechnology Inc
NAUTNASDAQ
Nautilus Biotechnology (NAUT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.14 | $-0.14 | $-0.14 |
| Actual | $-0.12 | $-0.11 | $-0.12 | $-0.11 |
| Surprise | +14.3% | +21.4% | +14.3% | +21.4% |
| Revenue | ||||
| Estimate | $205000 | — | — | — |
| Actual | $200000 | $190000 | $0 | $0 |
| Surprise | -2.44% | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.14 | $-0.14 | $-0.14 |
| Revenue | |||
| Consensus | $206000 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q2 | Jul 28, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Q1 | Apr 28, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q4 | Feb 26, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $200.00K | $205.00K | -2.44 % |
| Q1 | May 3, 2022 | $0 | $170.00K | -100.0 % |
